Cas:26250-90-8 (R,S)-Boc-3-amino-2-benzyl-propionic acid manufacturer & supplier

We serve Chemical Name:(R,S)-Boc-3-amino-2-benzyl-propionic acid CAS:26250-90-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(R,S)-Boc-3-amino-2-benzyl-propionic acid

Chemical Name:(R,S)-Boc-3-amino-2-benzyl-propionic acid
CAS.NO:26250-90-8
Synonyms:2-Benzyl-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)propanoic acid;2-Benzyl-3-[(tert-butoxycarbonyl)amino]propanoic acid;N-Boc-3-amino-2-benzylpropionic acid;Benzenepropanoic acid, α-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-
Molecular Formula:C15H21NO4
Molecular Weight:279.332
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:441.3±38.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.525
PSA:75.63000
Exact Mass:279.147064
LogP:3.03

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 2-Benzyl-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)propanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenepropanoic acid, α-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenepropanoic acid, α-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]- Use and application,2-Benzyl-3-[(tert-butoxycarbonyl)amino]propanoic acid technical grade,usp/ep/jp grade.


Related News: GBS is a rare but potentially life-threatening disorder in which the body’s immune system attacks nerve cells. The condition has been associated with the use of other widely used vaccines, such as GlaxoSmithKline’s Shingrix. 5,6,7,12,13,14-hexahydro-6,13-methanodibenzo(a,f)cyclodecen-15-one manufacturers Anifrolumab is a fully human monoclonal antibody that binds to subunit 1 of the type I interferon receptor, blocking the activity of type I interferons. 2-{2-[2-(5-bromo-2-methoxy-phenyl)-ethyl]-phenyl}-1-ethyl-4,5-dihydro-1H-imidazole suppliers MG is a “serious, lifelong disease with life-threatening manifestations, and most patients do not achieve treatment goals with conventional therapy,” the report said. N-(5,8-dimethoxy-quinoxalin-2-yl)-glycine vendor & factory.